Clinical Trial Update: IVF/ICSI Protocols in Poor Responders With Growth Hormone [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the use of growth hormone in IVF/ICSI protocols for poor responders with diminished ovarian reserve has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Infertility

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Female Infertility Due to Diminished Ovarian Reserve | Phase 4 | Status: COMPLETED